Hoertkorn Richard Charles’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Hoertkorn Richard Charles’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-500	Closed	-$12K	–	84
2019 Q4	$12K	Hold	500	–	–	0.01%	73
2019 Q3	$13K	Hold	500	–	–	0.01%	77
2019 Q2	$14K	Hold	500	–	–	0.01%	74
2019 Q1	$17K	Hold	500	–	–	0.01%	74
2018 Q4	$10K	Hold	500	–	–	0.01%	80
2018 Q3	$13K	Hold	500	–	–	0.01%	82
2018 Q2	$19K	Hold	500	–	–	0.01%	79
2018 Q1	$16K	Hold	500	–	–	0.01%	80
2017 Q4	$24K	Hold	500	–	–	0.01%	79
2017 Q3	$27K	Buy	+500	New	+$29.4K	0.02%	75

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Hoertkorn Richard Charles's PTLA Position: Q1 2020 in Review

Hoertkorn Richard Charles sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 500 shares — an estimated $12K sold.

Hoertkorn Richard Charles first reported a position in PTLA in Q3 2017 and held it in 10 quarters. The position peaked at $27K in Q3 2017. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Hoertkorn Richard Charles reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Hoertkorn Richard Charles sold 500 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $12K.
Hoertkorn Richard Charles first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 10 quarters.
Hoertkorn Richard Charles's Portola Pharmaceuticals, Inc. position peaked at $27K in Q3 2017.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Hoertkorn Richard Charles's 13F filing for Q1 2020, filed 1 May 2020.